November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

Combination Strategy Overcomes Drug Resistance in Preclinical Breast Cancer Models

🧠 AI Analysis 2 min read 👁 13

Researchers at UT MD Anderson used a computational platform to uncover a dual-drug approach that suppressed tumor growth in treatment-resistant breast cancer models.

Combination Strategy Overcomes Drug Resistance in Preclinical Breast Cancer Models🧠AI Analysis

Photo: Medical Xpress

Key points

  • UT MD Anderson researchers used a computational algorithm called TargetScore to identify cellular backup routes that drive drug resistance.
  • Simultaneously inhibiting the PARP and SHP2 pathways slowed tumor growth and extended survival in preclinical breast cancer models.
  • Clinical trials will be needed to confirm whether this combination therapy is safe and effective in human patients.

Researchers at The University of Texas MD Anderson Cancer Center have identified a dual-drug strategy that successfully bypassed treatment resistance in laboratory models of advanced breast cancer. The findings, published in the journal Cancer Research, relied on a novel computational algorithm called TargetScore to track how cancer cells adapt when exposed to therapeutic stress.

Investigators led by Anil Korkut, Ph.D., used TargetScore to analyze cellular responses after targeting MCL1, a protein that allows cancer cells to avoid programmed cell death. The algorithm revealed that under stress, breast cancer cells activated secondary survival routes governed by the PARP and SHP2 proteins, which control DNA repair and cellular growth. When researchers simultaneously inhibited both PARP and SHP2, the combination therapy significantly slowed tumor growth and prolonged survival in preclinical models compared to single-drug approaches. The effect was notably pronounced in cells with DNA repair defects that had already developed resistance to therapy.

What to know: These findings are based strictly on preclinical cell and animal models. While the computational approach highlights a potential strategy to counter drug resistance, clinical trials are necessary to confirm whether dual PARP and SHP2 inhibition is safe and effective for human patients. Individuals currently receiving treatment for breast cancer should discuss therapeutic options directly with their healthcare team.

Source Medical Xpress — medicalxpress.com/news/2026-11-combination-therapy-treatment-resistance… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.